A Prospective and Retrospective Registry and Biomarker Study to Evaluate the Natural History of Pediatric Patients with Cardiomyopathy due to MYBPC3 Mutations
Primary Objective
The objective of this study is to follow, characterize and evaluate the natural history of the disease course, burden of illness, risk factors, quality of life (QoL), and biomarkers associated with disease progression and treatments in pediatric patients with cardiomyopathy (CM) due to MYBPC3 pathogenic or likely pathogenic mutations.
Description
This is a natural history study.
Details
Age
Child
Eligibility
Children with a type of cardiomyopathy caused by a specific genetic mutation (MYBPC3 mutation) may be included in this research study.
Locations
Childrens Hospital Colorado
Principal Investigator
Stephanie Nakano
Study ID
Protocol Number: 21-4206
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers